$ARIA Recent Headlines Ariad takes another pounding after

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 6:17 PM

$ARIA Recent Headlines

Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad jumps on leukemia drug data 3:46 p.m. Dec. 6, 2010 - Val Brickates Kennedy

10-Q: ARIAD PHARMACEUTICALS INC 4:36 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 2:30 p.m. Today - Seeking Alpha
Sirius XM Will Host Baseball Giant Joe Torre and 2 Other Hot Stocks to Watch 12:14 p.m. Today - Wall St. Cheat Sheet
ARIAD Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Health-Care Stocks: Where to Find Value 6:07 a.m. Today - Barrons.com
JPMorgan Considers Ban on Trader Chat Rooms and 2 Other Hot Stocks to Watch 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:13 a.m. Nov. 11, 2013 - benzinga.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
EMA's PRAC Updates On The Risks Of Serious Vascular Occlusive Events Associated With Cancer Medicine Iclusig 8:37 a.m. Nov. 8, 2013 - benzinga.com
ARIAD Shares Tumble on Iclusig Woes - Analyst Blog 5:20 p.m. Nov. 7, 2013 - Zacks.com
ARIAD to Cut 40% of US Staff Positions 3:18 p.m. Nov. 7, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock 9:45 a.m. Nov. 6, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Canada Said to Have Blocked BlackBerry Takeover and 2 More Heavily Traded Stocks to Follow 4:59 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery 1:51 p.m. Nov. 4, 2013 - TheStreet.com
Ford Sees October Gains, Netflix Rides an Upgrade, and 3 More Hot Stocks 1:52 p.m. Nov. 1, 2013 - Wall St. Cheat Sheet
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Are You Betting Too Much On Theravance? 11:28 a.m. Nov. 1, 2013 - Seeking Alpha
Analysts: Facebook Could Add $3B in Revenue and 3 More Research Notes to Browse 10:22 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update 6:00 a.m. Nov. 1, 2013 - TheStreet.com

ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Today - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Today - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Today - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE
ARIAD Announces Reduction in U.S. Workforce as Part of Broad Program to Reduce Operating Expenses 4:05 p.m. Nov. 7, 2013 - BusinessWire
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Ariad Pharmaceuticals, Inc. 8:10 p.m. Nov. 5, 2013 - PR Newswire
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig 12:50 p.m. Nov. 5, 2013 - PR Newswire
Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo 8:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Equity Reports on BZNE, ARIA, AXPW and SPDL 2:25 a.m. Nov. 4, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. 9:32 p.m. Nov. 1, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits 8:35 a.m. Nov. 1, 2013 - BusinessWire
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013 4:30 p.m. Oct. 31, 2013 - BusinessWire
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States 7:30 a.m. Oct. 31, 2013 - BusinessWire
ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 3:36 p.m. Oct. 30, 2013 - GlobeNewswire
Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD 9:08 a.m. Oct. 30, 2013 - PR Newswire
Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:30 p.m. Oct. 29, 2013 - BusinessWire
Insider Trading Reports for Intel, Charles Schwab, Fusion-IO, J.C. Penney, Bristol-Myers Squibb, and Ariad Pharmaceuticals 8:55 a.m. Oct. 29, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pollo Campero Unveils Bold New Sauces Nationwide

New Sauces Add Flavor Punch to Pollo Campero's Offerings Some days, you're just in the mood to shake things up. That's likely the thinking at Pollo Campero with their latest move: rolling out a trio of sauces that promises to give the taste buds something to talk about. These aren't just any sauces, mind you—this is a strategic gem from the chicken joint known for...

Princess Cruises Plots Grand Odyssey for 2028–29 Season

Princess Cruises: Setting Sail for Uncharted Waters We're not talking about your regular trips along the coast. Princess Cruises is rolling out the anchor for what's set to be a jaw-dropping season in Australia and New Zealand come 2028–29. Now, I know these cruise folks love a grand unveiling, but this one is something else. They've got the longest ever roundtrip World...

Heart Attack vs. Cardiac Arrest: Know the Differences

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Beacon AI's Murdock Flies into the Future for USAF

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Trip.com Drives Sustainability with New Travel Impact Tool

Sustainability Takes Center Stage in Travel Plans So here's the deal: Traveling isn't just about snapping pictures of breathtaking views or rounding up souvenirs anymore. These days, people are increasingly keen on ensuring their trips don't leave a hefty carbon footprint. With the release of Trip.com's 2026 Sustainable Travel Consumer Report, it's clear that the winds...

Gilded Dragonfly Gallery: A Jewel in Brunswick's Crown

There's something remarkable happening in Brunswick, Maryland. This small town's stirring to life with a splash of creativity, and it's just gotten a little brighter with the grand opening of the Gilded Dragonfly Gallery. This isn't just another art gallery popping up; it's a statement of transformation, from quiet exurbia to a thriving arts destination. Jayme Marshall:...

Vero Beach's Soaring Popularity: A Real Estate Surge?

Vero Beach: A Rising Star in Travel Trends Who would've thought Vero Beach, that quiet escape with a nod to old-school Florida, would suddenly find itself in the spotlight? Skyscanner's Travel Trends report thrusts this charming coastal town to the top of the list for 2027, ahead of hotspots like Bimini and Olbia. An impressive 201% increase in flight searches has...

Philips’ Beauty Tech Trends Promise Intimacy by 2027

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

Ecopetrol Sets Q3 2026 Results Release, Conference Call

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

Etisalat Surges: Net Profit Soars 46% Amid Growth

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...